General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Actelion(MODEST), CERENO(SIGNIFICANT), United therapeutics (MODEST), keros(MODEST), insmed(MODEST), Merck & Co., Inc.(NONE), United therapy (MODEST), Abbott Laboratories(MODEST) RESEARCH/RESEARCH GRANTS: gossamer(MODEST)
